Skip to main content

Table 1 Demographic, clinical, and laboratory characteristics of patients

From: Prevalence and prognostic value of plasma glucose abnormalities among full-term and late-preterm neonates with sepsis

Characteristic

Survivors (n = 135 )

Non-survivors (n = 39 )

All patients (n = 174)

P value

Postnatal age, days

7 (1–27)

11 (1–27)

8 (1–27)

0.001*

Female sex

62 (45.9%)

16 (41%)

78 (45%)

0.59

Weight, kg

2.73 ± 0.58

2.46 ± 0.71

2.66 ± 0.62

0.022*

Gestational age, week

38 (35–40)

37 (35–42)

37.5 (35–42)

0.25

Preterm

34 (25.2%)

15 (38.5%)

49 (28.2%)

0.1

Full term

101 (74.8%)

24 (61.5%)

125 (71.8%)

Cesarean delivery

108 (80%)

33 (84.6%)

141 (81%)

0.52

Early-onset sepsis

37 (27.4%)

8 (20.5%)

45 (25.8%)

0.39

Late-onset sepsis

98 (72.6%)

31 (79.5%)

129 (74.1%)

Proven sepsis

47 (34.8%)

26 (66.7%)

73 (42%)

< 0.001*

Possible sepsis

88 (65.2%)

13 (33.3)

101 (58%)

Invasive mechanical ventilation

76 (56.3%)

35 (89.7%)

111 (63.8%)

< 0.001*

Type of organism

0.48

 Gram positive

14 (10.4%)

5 (12.8%)

19 (10.9%)

 Gram negative

29 (21.5%)

17 (43.6%)

46 (26.4%)

Candida

4 (3%)

4 (10.3%)

8 (4.6%)

Glycemic status

0.024*

 High

14 (10.4%)

8 (20.5%)

22 (12.6%)

 Low

10 (7.4%)

9 (23.1%)

19 (10.9%)

 Normal

111 (82.2%)

22 (56.4%)

133 (76.4%)

CRP, mg/dL

27 (0–289)

77 (2–316)

47 (0–316)

0.015*

WBC (× 1000/mL)

12.9 (2.7–51)

11.5 (2.7–50)

12.6 (2.7–51)

0.32

Platelets (× 1000/mL)

162 (5–648)

40 (4–676)

141 (4–676)

< 0.001*

Hemoglobin, g/dL

12.84 ± 3.11

11.73 ± 2.51

12.6 ± 3.01

0.042*

Creatinine, mg/dL

0.6 (0.2–2.7)

0.6 (0.16–1.2)

0.6 (0.16–2.7)

0.89

  1. Data is presented as number (percentage), mean ± standard deviation, or median (minimum–maximum)
  2. CRP C-reactive protein, WBC white blood cell count.
  3. *Statistically significant